Posts by: Patricia Inacio, PhD

Patricia Inacio, PhD

Patricia holds a Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She has also served as a PhD student research assistant at the Department of Microbiology & Immunology, Columbia University, New York.

October 17, 2019October 17, 2019

Nourianz Now Available in US as Add-on to Carbidopa/Levodopa to Treat Parkinson’s Off Periods

News

Kyowa Kirin’s Nourianz (istradefylline) tablets are now available in the United States as an add-on treatment for off periods in Parkinson’s disease patients on a carbidopa/levodopa regimen. Off periods — ... Read more

October 14, 2019October 14, 2019

Researchers Using Real-time Brain Mapping to Search for Therapeutic Targets in PD

News

Using its brain mapping platform, Inscopix will team up with researchers at the Broad Institute of MIT and Harvard to investigate how changes in brain activity alter the functioning ... Read more

October 3, 2019October 3, 2019

Silverstein Foundation, Q-State Launch Company Aiming to Treat Parkinson’s Linked to GBA Mutations

News

The Silverstein Foundation for Parkinson’s with GBA together with Q-State Biosciences have launched Chamishi Therapeutics, a company aiming to develop innovative treatments for Parkinson’s disease and other neurodegenerative diseases. Chamishi ... Read more

September 18, 2019September 18, 2019

CRISPR/Cas9’s Potential in Better Understanding and Treating Parkinson’s Focus of Review Study

News

In a recent review, scientists highlight the potential of gene editing technologies like CRISPR/Cas9 to not only understand the molecular mechanisms behind Parkinson’s disease, but also identify new targets ... Read more

September 16, 2019September 16, 2019

New MRI Technique Can Visualize Brain Molecular Composition, Study Shows

News

A new magnetic resonance imaging (MRI) technique allows for the visualization of molecular changes in the brain, a study reports. This technique will allow researchers to further understand how ... Read more

September 12, 2019September 12, 2019

Early Trial for Prevail’s One-time Gene Therapy PR001 to Start Soon

News

Prevail Therapeutics will soon start its Phase 1/2 clinical trial evaluating the safety, tolerability, and early efficacy of its one-time gene therapy — called PR001 — for Parkinson’s disease associated ... Read more

August 29, 2019August 29, 2019

Nourianz Approved in US as Add-on Therapy to Carbidopa/Levodopa to Treat Off Periods in Parkinson’s

News

The U.S Food and Drug Administration (FDA) has approved Kyowa Kirin’s Nourianz (istradefylline) tablets as an add-on therapy to treat off periods in Parkinson’s disease patients on a carbidopa/levodopa regimen. ... Read more

August 28, 2019August 28, 2019

Rescuing Activity of Specific Neurons Improved Motor Function in Parkinson’s Mice

News

Rescuing the activity of neurons in the subthalamic nucleus — part of a brain region that controls movement — lessens motor dysfunction in a mouse model of Parkinson’s disease ... Read more

August 27, 2019August 27, 2019

PPMI RNA-Sequencing, the Largest Dataset of Gene Activity in Parkinson’s, Now Available to Researchers

News

The largest dataset ever compiled on Parkinson’s disease research — equivalent to 47.5 billion single-spaced typed pages — is now available to scientists, and can be used to investigate ... Read more

August 15, 2019

Parkinson’s UK Awards Scientist £100,000 to ID Ways of Protecting Dopamine-producing Neurons

News

A scientist at the University of Sheffield in England has been awarded a £100,000 grant by Parkinson’s UK to develop a treatment that might slow or stop the progression of ... Read more

Pin It on Pinterest